The global cannabidiol market size is anticipated to reach USD 39.74 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.9% from 2026 to 2033. Changing consumer attitudes towards CBD products, shifting public opinion, and growing recognition of the health benefits of cannabidiol are some of the main factors contributing to the market's growth. The cannabis Sativa plant contains more than 80 cannabinoids, but cannabidiol is the most widely used for medical purposes because of its lack of psychoactive effects. It is primarily obtained from hemp due to its high CBD content.
There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. CBD can enter the human body through different means, including vaping, smoking, and through the skin. In the U.S., where cannabis is legal, CBD is utilized to produce personal care products and medical drugs. Legalizing cannabis-based products has opened up significant opportunities for various end-use industries to expand their product offerings.
Major players in the industry are focused on introducing CBD-infused products. Companies are exploring opportunities in international markets as the demand for CBD grows globally. Furthermore, they are investing in research and development to enhance the effectiveness and efficiency of their products, as well as to expand their offerings. The players are introducing new and innovative products, such as edibles, topicals, and beverages, to cater to the growing demand. For instance, in May 2022, Medical Marijuana, Inc. announced the launch of a pharma subsidiary in Brazil named “HM Pharma” to expand its access to CBD products in pharmacies.
Request a free sample copy or view report summary: Cannabidiol Market Report
North America accounts for the largest with a market share of 66.5% in 2025 owing to the presence of major manufacturers, and approval of the U.S. Farm Bill are some of the major factors driving the growth of the region.
Hemp-derived CBD dominated the market in 2025, with a market share owing to its higher purity and potential health benefits.
B2B segment accounts for the largest market share in 2025 owing to increasing demand and a rising number of businesses using cannabidiol as raw materials.
In 2025, the pharmaceuticals segment accounted for the largest market share in the end-use market owing to rising use of cannabis derivate for various medical conditions.
Grand View Research has segmented the global cannabidiol market based on source, product, application, formulation, distribution channel, and region:
Cannabidiol Source Outlook (Revenue, USD Million, 2021 - 2033)
Hemp-derived CBD
Marijuana derived CBD
Cannabidiol Product Outlook (Revenue, USD Million, 2021 - 2033)
OTC CBD Products
CBD Oil & Tinctures (Drops)
CBD Capsules
Topicals (Creams, Balms, Skincare)
Edibles (Gummies, Beverages, Functional Foods)
Vape Products
Pharmaceutical-grade CBD (Rx formulations)
Oral solutions (CBD Oils, Tinctures/Drops)
Capsules
Cannabidiol Application Outlook (Revenue, USD Million, 2021 - 2033)
Medical / Therapeutic Use
Wellness & Lifestyle
Personal Care & Cosmetics
Food & Beverage
Others (Pet care, niche uses)
Cannabidiol Formulation Outlook (Revenue, USD Million, 2021 - 2033)
Full-spectrum CBD
Broad-spectrum CBD
CBD Isolate
Cannabidiol Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
E-commerce / Online Platforms
Retail Pharmacies
Specialty Stores (CBD stores, wellness shops)
Supermarkets/Hypermarkets
Hospitals & Clinics (Rx CBD)
Cannabidiol Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Italy
France
Netherlands
Switzerland
Spain
Poland
Czech Republic
Croatia
Asia
China
India
Japan
Thailand
Oceania
Australia
New Zealand
Latin America & Caribbean
Brazil
Uruguay
Colombia
Argentina
Africa
List Of Key Players in the Cannabidiol Market
ENDOCA
Cannoid, LLC
Medical Marijuana, Inc.
Folium Europe B.V.
Canopy Growth Corporation
Elixinol
NuLeaf Naturals, LLC
Isodiol International, Inc.
PharmaHemp
The Cronos Group
"The quality of research they have done for us has been excellent..."